Monoprost (Latanoprost)

Latanoprost, the active ingredient in Monoprost, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in adult and elderly patients with primary open‑angle glaucoma or ocular hypertension, helping to preserve visual function.

GNH USA supplies Monoprost as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides full regulatory documentation to support global distribution and clinical use through reliable supply chains.

Latanoprost is a prostaglandin analog used to manage ocular pressure in glaucoma and ocular hypertension.

- Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma. - Pseudoexfoliative glaucoma: helps control intra‑ocular pressure in this secondary form of open‑angle glaucoma.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris pigmentation: gradual darkening of eye colour. - Eye irritation: foreign‑body sensation or mild discomfort. - Blurred vision: temporary visual disturbance after instillation. - Periorbital skin darkening: mild hyperpigmentation of surrounding skin.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation inside the eye requiring urgent care. - Macular edema: fluid accumulation in the central retina. - Ocular infection: signs of bacterial or fungal infection. - Vision loss: sudden decrease in visual acuity. - Persistent hypotony: excessively low intra‑ocular pressure.

When prescribing or using Monoprost, consider the following precautions.

- Monitor IOP: regular intra‑ocular pressure measurements are essential. - Assess for ocular inflammation: avoid use in active eye infections or uveitis. - Caution with contact lens wearers: may cause lens deposits. - Pregnancy and lactation: safety not established; consult a physician. - History of ocular surgery: evaluate risk of delayed healing. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concomitant prostaglandin analogs: additive IOP lowering may cause hypotony. - Non‑steroidal anti‑inflammatory eye drops: may reduce latanoprost efficacy. - Systemic carbonic anhydrase inhibitors: increased risk of ocular side effects.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive IOP reduction requires monitoring. - Alpha‑agonist eye drops: combined effect on pressure may need adjustment. - Topical corticosteroids: may diminish IOP‑lowering effect of latanoprost.